The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding AG as ...

Investing.com -- The White House is preparing to announce drug pricing agreements with Swiss pharmaceutical giants Novartis ...

ZURICH (Reuters) - Swiss drugmaker Roche (ROG.S) said it will put a cancer specialist at the helm of its Swiss-based research efforts in April, after the scientist who led the unit for five years ...

Basel, 14 October 2013- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced plans to invest 800 million Swiss francs within its global manufacturing network to increase production capabilities for its ...

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company, ...

Roche said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by 30% compared ...

Basel, 5 November 2014- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it will invest 450 million Swiss Francs over the next three years to establish a new diagnostic manufacturing facility at the ...

July 21 (Reuters) - Roche's (ROG.S), opens new tab head of diagnostics, Thomas Schinecker, is to take over as group chief executive next year, replacing Severin Schwan, who will become chairman after ...

Roche is a leader in biotechnology, cancer treatment and diagnostics. 28 years of consecutive dividend growth and a 10-year dividend growth rate of 14.87 percent. Recent dividend growth has been low ...

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company, ...